AZD7325 single ascending dose study in healthy male Japanese subjects - JSAD

Exclusion Criteria

• - Clinically relevant disease and/or abnormalities (past or present)
• - Clinically relevant abnormalities in physical examinations,vital signs,clinical chemistry, hematology or urinalysis at screening as judged by the investigator
• - Use of any medication or herbal preparation within 14 days of Study day 1 through the Follow-up Visit other than paracetamol (up to 3 g/day)
• - Smoking in excess of 5 cigarettes per day or the equivalent within 28 days prior to the first study day or inability to refrain from smoking during the study confinement period